Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Kutter

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Pharmaceutics|October 15, 2020
Storage stability of phage-ciprofloxacin combination powders against Pseudomonas aeruginosa respiratory infectionsYu Lin, Rachel Yoon Kyung Chang, Warwick J Britton, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 10, 2019
Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infectionsYu Lin, Rachel Yoon Kyung Chang, Warwick J Britton, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 12, 2017
Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infectionRachel Y Chang, Jennifer Wong, Ash Mathai, et al.
Journal of Bacteriology|December 4, 2004
Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in BangladeshSandra Chibani-Chennoufi, Josette Sidoti, Anne Bruttin, et al.
Plos One|May 3, 2013
The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophagesChristiane Essoh, Yann Blouin, Guillaume Loukou, et al.
Bioengineering & Translational Medicine|May 23, 2020
Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilizationRachel Yoon Kyung Chang, Philip Chi Lip Kwok, Dipesh Khanal, et al.
Food Microbiology|September 20, 2020
Development of a broad-spectrum Salmonella phage cocktail containing Viunalike and Jerseylike viruses isolated from ThailandPreeda Phothaworn, Rattaya Supokaivanich, Jiali Lim, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2017
Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder FormulationRachel Yoon Kyung Chang, Ke Chen, Jiping Wang, et al.
Microbial Biotechnology|April 13, 2011
Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogensLeila Kvachadze, Nana Balarjishvili, Tamila Meskhi, et al.
International Journal of Pharmaceutics|November 17, 2018
Jet nebulization of bacteriophages with different tail morphologies - Structural effectsSharon Shui Yee Leung, Nicholas B Carrigy, Reinhard Vehring, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|October 15, 2020
Storage stability of phage-ciprofloxacin combination powders against Pseudomonas aeruginosa respiratory infectionsYu Lin, Rachel Yoon Kyung Chang, Warwick J Britton, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 10, 2019
Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infectionsYu Lin, Rachel Yoon Kyung Chang, Warwick J Britton, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 12, 2017
Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infectionRachel Y Chang, Jennifer Wong, Ash Mathai, et al.
Journal of Bacteriology|December 4, 2004
Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in BangladeshSandra Chibani-Chennoufi, Josette Sidoti, Anne Bruttin, et al.
Plos One|May 3, 2013
The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophagesChristiane Essoh, Yann Blouin, Guillaume Loukou, et al.
Bioengineering & Translational Medicine|May 23, 2020
Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilizationRachel Yoon Kyung Chang, Philip Chi Lip Kwok, Dipesh Khanal, et al.
Food Microbiology|September 20, 2020
Development of a broad-spectrum Salmonella phage cocktail containing Viunalike and Jerseylike viruses isolated from ThailandPreeda Phothaworn, Rattaya Supokaivanich, Jiali Lim, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2017
Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder FormulationRachel Yoon Kyung Chang, Ke Chen, Jiping Wang, et al.
Microbial Biotechnology|April 13, 2011
Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogensLeila Kvachadze, Nana Balarjishvili, Tamila Meskhi, et al.
International Journal of Pharmaceutics|November 17, 2018
Jet nebulization of bacteriophages with different tail morphologies - Structural effectsSharon Shui Yee Leung, Nicholas B Carrigy, Reinhard Vehring, et al.
Pageof 5